FotoFinder Systems

FotoFinder Systems

FotoFinder Systems GmbH was founded in 1991 in Bad Birnbach, Bavaria, initially as a medical imaging hardware manufacturer. The company carved an early niche in digital dermoscopy, developing camera systems that allowed dermatologists to map and monitor moles with standardized, reproducible imaging. Over three decades, the product line expanded to include automated total-body mapping systems and software for the early detection of malignant melanoma. The company's core intellectual property lies in its integration of proprietary imaging optics with machine-learning-based analysis tools. Its ATBM (Automated Total Body Mapping) and dynamic dermoscopy stations combine high-resolution camera arrays with software that identifies new, changed, or clinically suspicious lesions across sequential patient visits. Deployment concentrates on dermatology practices and hospital outpatient departments, with an installed base spanning Germany, other European Union member states, and selected Asian and Middle Eastern markets. The firm operates a direct-sales model supplemented by regional distributors, and has deepened clinical ties through research collaborations that generate the annotated image datasets used to refine its diagnostic support algorithms. Headquartered in Bad Birnbach, the firm is led by an engineering and clinical-advisory team oriented around optical system design and regulatory compliance for Class IIa medical devices. In May 2024, the company announced a new generation of its body-mapping platform designed to reduce scan time while increasing lesion-tracking fidelity, integrated with cloud-based teleconsultation workflows. This product cycle reflects a broader push into software-as-a-medical-device recurring revenue, layering AI-driven decision-support atop the hardware install base. FotoFinder's structural differentiator is its tight coupling of custom optical hardware with a clinically rigorous, longitudinally annotated image database unique to its user network. Unlike pure-play software vendors that rely on third-party dermatoscope attachments and heterogeneous image sources, the company controls the image-acquisition standard, the annotation protocol, and the training data pipeline—an architecture that makes it difficult to replicate without a comparable installed device fleet.